Gene Therapy for Mucopolysaccharidosis and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Gene Therapy for Mucopolysaccharidosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Therapy for Mucopolysaccharidosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Therapy for Mucopolysaccharidosis Overall Market Size
2.1 Global Gene Therapy for Mucopolysaccharidosis Market Size: 2022 VS 2029
2.2 Global Gene Therapy for Mucopolysaccharidosis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Therapy for Mucopolysaccharidosis Players in Global Market
3.2 Top Global Gene Therapy for Mucopolysaccharidosis Companies Ranked by Revenue
3.3 Global Gene Therapy for Mucopolysaccharidosis Revenue by Companies
3.4 Top 3 and Top 5 Gene Therapy for Mucopolysaccharidosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Therapy for Mucopolysaccharidosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy for Mucopolysaccharidosis Players in Global Market
3.6.1 List of Global Tier 1 Gene Therapy for Mucopolysaccharidosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Therapy for Mucopolysaccharidosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Therapy for Mucopolysaccharidosis Market Size Markets, 2022 & 2029
4.1.2 Intravenous
4.1.3 ICV
4.1.4 Intracerebral
4.1.5 Intracisternal
4.2 By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue & Forecasts
4.2.1 By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2023
4.2.2 By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue, 2024-2029
4.2.3 By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Therapy for Mucopolysaccharidosis Market Size, 2022 & 2029
5.1.2 Mucopolysaccharidosis I
5.1.3 Mucopolysaccharidosis II
5.1.4 Mucopolysaccharidosis III A
5.1.5 Mucopolysaccharidosis III B
5.2 By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue & Forecasts
5.2.1 By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2023
5.2.2 By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue, 2024-2029
5.2.3 By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Therapy for Mucopolysaccharidosis Market Size, 2022 & 2029
6.2 By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue & Forecasts
6.2.1 By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2023
6.2.2 By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue, 2024-2029
6.2.3 By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2029
6.3.2 US Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.3.3 Canada Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.3.4 Mexico Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2029
6.4.2 Germany Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4.3 France Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4.4 U.K. Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4.5 Italy Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4.6 Russia Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4.7 Nordic Countries Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.4.8 Benelux Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2029
6.5.2 China Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.5.3 Japan Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.5.4 South Korea Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.5.5 Southeast Asia Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.5.6 India Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2029
6.6.2 Brazil Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.6.3 Argentina Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2029
6.7.2 Turkey Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.7.3 Israel Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
6.7.5 UAE Gene Therapy for Mucopolysaccharidosis Market Size, 2018-2029
7 Gene Therapy for Mucopolysaccharidosis Companies Profiles
7.1 Sangamo Therapeutics
7.1.1 Sangamo Therapeutics Company Summary
7.1.2 Sangamo Therapeutics Business Overview
7.1.3 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Major Product Offerings
7.1.4 Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Revenue in Global Market (2018-2023)
7.1.5 Sangamo Therapeutics Key News & Latest Developments
7.2 Swedish Orphan Biovitrum
7.2.1 Swedish Orphan Biovitrum Company Summary
7.2.2 Swedish Orphan Biovitrum Business Overview
7.2.3 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Major Product Offerings
7.2.4 Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Revenue in Global Market (2018-2023)
7.2.5 Swedish Orphan Biovitrum Key News & Latest Developments
7.3 uniQure
7.3.1 uniQure Company Summary
7.3.2 uniQure Business Overview
7.3.3 uniQure Gene Therapy for Mucopolysaccharidosis Major Product Offerings
7.3.4 uniQure Gene Therapy for Mucopolysaccharidosis Revenue in Global Market (2018-2023)
7.3.5 uniQure Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Gene Therapy for Mucopolysaccharidosis Market Opportunities & Trends in Global Market
Table 2. Gene Therapy for Mucopolysaccharidosis Market Drivers in Global Market
Table 3. Gene Therapy for Mucopolysaccharidosis Market Restraints in Global Market
Table 4. Key Players of Gene Therapy for Mucopolysaccharidosis in Global Market
Table 5. Top Gene Therapy for Mucopolysaccharidosis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Therapy for Mucopolysaccharidosis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Therapy for Mucopolysaccharidosis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Therapy for Mucopolysaccharidosis Product Type
Table 9. List of Global Tier 1 Gene Therapy for Mucopolysaccharidosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Therapy for Mucopolysaccharidosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Therapy for Mucopolysaccharidosis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Therapy for Mucopolysaccharidosis Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Therapy for Mucopolysaccharidosis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Therapy for Mucopolysaccharidosis Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2024-2029
Table 30. Sangamo Therapeutics Company Summary
Table 31. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Product Offerings
Table 32. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Revenue (US$, Mn) & (2018-2023)
Table 33. Sangamo Therapeutics Key News & Latest Developments
Table 34. Swedish Orphan Biovitrum Company Summary
Table 35. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Product Offerings
Table 36. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Revenue (US$, Mn) & (2018-2023)
Table 37. Swedish Orphan Biovitrum Key News & Latest Developments
Table 38. uniQure Company Summary
Table 39. uniQure Gene Therapy for Mucopolysaccharidosis Product Offerings
Table 40. uniQure Gene Therapy for Mucopolysaccharidosis Revenue (US$, Mn) & (2018-2023)
Table 41. uniQure Key News & Latest Developments
List of Figures
Figure 1. Gene Therapy for Mucopolysaccharidosis Segment by Type in 2022
Figure 2. Gene Therapy for Mucopolysaccharidosis Segment by Application in 2022
Figure 3. Global Gene Therapy for Mucopolysaccharidosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Therapy for Mucopolysaccharidosis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Therapy for Mucopolysaccharidosis Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Therapy for Mucopolysaccharidosis Revenue in 2022
Figure 8. By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 16. US Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 20. Germany Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 28. China Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Therapy for Mucopolysaccharidosis Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Therapy for Mucopolysaccharidosis Revenue, (US$, Mn), 2018-2029
Figure 41. Sangamo Therapeutics Gene Therapy for Mucopolysaccharidosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Swedish Orphan Biovitrum Gene Therapy for Mucopolysaccharidosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. uniQure Gene Therapy for Mucopolysaccharidosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
